A delegation of biotechnology businesses from America’s life sciences hub, Maryland, will be visiting the Midlands’ key life sciences sites and meeting with the region’s biotech companies in March as part of a tour supported by the Department for International Trade (DIT).
The event is an opportunity for Midlands businesses to meet potential buyers from some of the world’s top biolabs. And, with a reputation for excellence in bioscience and more than 1,100 life sciences businesses located in the Midlands, the region offers unparalleled opportunity for businesses from both sides of the pond to develop relationships.
From 5–7 March, 11 cutting-edge biotechnology businesses from Maryland that are using cellular and biomolecular processes to develop and manufacture medicines will tour Nottingham, Leicester and Birmingham. The day trips will include visits to Nottingham University Hospital and Nottingham’s healthcare business incubator, BioCity; the Charnwood Campus in Loughborough; and the University of Birmingham’s Institute of Translational Medicine.
The tour will also include one-to-one meetings with Midlands biotech businesses including Biotech Diagnostics and Total Child Health, inc for networking, developing exporting contacts, and exchanging ideas at an event hosted by Simon Hall, Deputy Director of UK Regions at the Midlands Engine.
Maryland is one of the world’s biotech powerhouses, home to some of the first labs in the world to map the human genome and develop the first rapid test for Ebola. The state is the fourth-largest biotech cluster in the US, according to research by Genetic Engineering and Biotechnology Magazine.
Midlands firms who would like to attend and meet potential stateside partners should register via https://www.eventbrite.co.uk/e/maryland-midlands-biotech-collaboration-visit-tickets-46567062337 by Monday 4th of March.